COSTANZA RAMON-MAXWELL: Open Payments
NPI 1578674867 · KILLEEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 5 payments from 4 companies in 2025. Trend: 2023 $36 · 2024 $247 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $121 |
| GENZYME CORPORATION | 1 | $115 |
| AstraZeneca Pharmaceuticals LP | 1 | $103 |
| Dexcom, Inc. | 2 | $85 |
Products named: REZDIFFRA, DUPIXENT, FARXIGA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
